Angiotensin converting enzyme inhibitors (ACEI) and angiotensin AT1 receptor antagonists are frequently being used to prevent the development of target organ damage in atherosclerotic disease and in hypertension [37]. The gene discussed is ACE; the disease is hypertensive disorder.